We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVV icon
2351
Ovintiv
OVV
$17B
$1K ﹤0.01%
187
-1,216
-87% -$8.48K
PEBO icon
2352
Peoples Bancorp
PEBO
$1.51B
$1K ﹤0.01%
63
-325
-84% -$7.11K
PEN icon
2353
Penumbra
PEN
$12.6B
$1K ﹤0.01%
+6
New +$1.04K
PODD icon
2354
Insulet
PODD
$11.8B
$1K ﹤0.01%
10
-30
-75% -$5.74K
POWL icon
2355
Powell Industries
POWL
$6.79B
$1K ﹤0.01%
165
-96
-37% -$816
PRI icon
2356
Primerica
PRI
$10.1B
$1K ﹤0.01%
+10
New +$1.06K
HTT
2357
High Templar Tech Ltd
HTT
$370M
$1K ﹤0.01%
1,000
QDEL icon
2358
QuidelOrtho
QDEL
$1.13B
$1K ﹤0.01%
+6
New +$940
RARE icon
2359
Ultragenyx Pharmaceutical
RARE
$2.46B
$1K ﹤0.01%
14
RCKT icon
2360
Rocket Pharmaceuticals
RCKT
$343M
$1K ﹤0.01%
+89
New +$1.6K
RES icon
2361
RPC Inc
RES
$1.13B
$1K ﹤0.01%
439
RGS icon
2362
Regis Corp
RGS
$68.4M
$1K ﹤0.01%
9
RLJ icon
2363
RLJ Lodging Trust
RLJ
$1.88B
$1K ﹤0.01%
+121
New +$1.13K
RMR icon
2364
The RMR Group
RMR
$335M
$1K ﹤0.01%
58
+57
+5,700% +$1.65K
RPD icon
2365
Rapid7
RPD
$628M
$1K ﹤0.01%
+22
New +$1.02K
RYTM icon
2366
Rhythm Pharmaceuticals
RYTM
$7.31B
$1K ﹤0.01%
+50
New +$975
SIBN icon
2367
SI-BONE Inc
SIBN
$818M
$1K ﹤0.01%
+97
New +$1.53K
SPHR icon
2368
Sphere Entertainment
SPHR
$5.02B
$1K ﹤0.01%
+26
New +$2K
SUI icon
2369
Sun Communities
SUI
$15.8B
$1K ﹤0.01%
+10
New +$1.33K
SWBI icon
2370
Smith & Wesson
SWBI
$649M
$1K ﹤0.01%
78
TALO icon
2371
Talos Energy
TALO
$2.38B
$1K ﹤0.01%
+148
New +$1.54K
TG icon
2372
Tredegar Corp
TG
$260M
$1K ﹤0.01%
110
THS
2373
DELISTED
Treehouse Foods
THS
$1K ﹤0.01%
28
-169
-86% -$8.24K
TISI icon
2374
Team
TISI
$80.6M
$1K ﹤0.01%
28
-20
-42% -$1.1K
TKC icon
2375
Turkcell
TKC
$4.7B
$1K ﹤0.01%
197
-1,552
-89% -$7.92K

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.